Cannara Biotech Secures Preliminary Approval in Quebec for Five Vapes, Eyes November 2025 Launch

Jul.25.2025
Cannara Biotech Secures Preliminary Approval in Quebec for Five Vapes, Eyes November 2025 Launch
Cannara Biotech Inc. says five of its cannabis vapes have received preliminary approval from Quebec’s SQDC and are set to launch in November 2025 in stores and online. The products make up 20% of SQDC’s year-end vape offerings and feature premium, additive-free formulas. Cannara’s live resin vapes were Canada’s top-selling premium brand over the past year.

Key points:

 

·Product approval: Five cannabis e-cigarette products from Cannara Biotech have received preliminary acceptance from Quebec SQDC in Canada. 

 

·Launch date: The plan is to have them available in retail stores across Quebec and on the SQDC.ca e-commerce platform in November 2025. 

 

·Market share: These five products will make up 20% of the 25 cannabis e-cigarette products sold by SQDC by the end of the year. 

 

·Product features: All of them are high-end, additive-free formulas that comply with Quebec regulations and consumer preferences. 

 

·Market coverage: By entering the Quebec market, Cannara has now covered all four major provinces in Canada with cannabis e-cigarette products, as Quebec was the only one without them before.

 


【2Firsts News Flash】Canadian cannabis company Cannara Biotech Inc announced that its five cannabis e-cigarette products have been preliminarily accepted by the Société Québécoise du Cannabis (SQDC), the government-authorized cannabis retailer in Quebec. The products are set to be available for purchase in retail stores across Quebec and on the SQDC's online platform SQDC.ca in November 2025.

 

These five products will account for 20% of the 25 cannabis e-cigarette products that SQDC plans to sell by the end of the year. The products include live resin and live rosin type e-cigarettes, all of which are high-end and additive-free formulas, emphasizing compliance with Quebec regulations and consumer preferences.

 

Cannara claims that its line of active resin e-cigarettes has become the top-selling high-end brand in Canada over the past year. Its entry into the Quebec market marks its completion of coverage in all four major provinces in Canada that had not yet introduced marijuana e-cigarette products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08
  South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea’s cigarette tax debate has resurfaced after the Ministry of Health and Welfare said tobacco price policy needed review, with a poll showing 63% of respondents support higher tobacco taxes.
Regulations
Jun.22
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai